Effect of isoproterenol on arrhythmia recurrence after treatment with ablation

Study the effect of isoperentenol on the recurrence of arrhythmia in patients with Atrioventricular Nodal Reentrant tachycardia arrhythmia treated with ablation

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016110630756N1

Enrollment

120

Registered

2017-08-01

Start date

2016-05-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrioventricular Nodal Reentrant Tachycardia Arrhythmia. Supraventricular Tachycardia

Interventions

Intervention 1: Intervention group: Prescribing isoproterenol at a dose of 0.5 to 4 µg/min to increase heart rate to 25% of the initial beat. Intervention 2: Control group: Routine care.

Treatment - Other

Intervention group: Prescribing isoproterenol at a dose of 0.5 to 4 µg/min to increase heart rate to 25% of the initial beat

Control group: Routine care

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: arrhythmia AVNRT; the creation of AVNRT arrhythmias without prescription Isoproterenol; No repeat arrhythmia after standard ablation therapy (with and without isoproterenol). Exclusion criteria: Arrhythmia that can only be induced by Isoproterenol; medical prohibition of Isoproterenol

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Recurrence of AtrioventricularNodal Reentery. Timepoint: 12th Month After Discharge. Method of measurement: History.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSaeed Mehrabi

Mashhad University of Medical Sciences

mehrabis931.mums.ac.ir; saeedmehrabi_313@yahoo.com+98 51 3882 0884

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026